Key facts
- This page summarizes David J. Wilson's Form 4 filing for Microbot Medical Inc. (MBOT).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 03 Apr 2026, 16:30.
David J. Wilson - 01 Apr 2026 Form 4 Insider Report for Microbot Medical Inc. (MBOT)
- Reporting relationship
- Director
- Issuer ticker
- MBOT
- Reported as of
- 01 Apr 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Apr 2026, 16:30:38 UTC
- Prior SEC filing
- 30 Jan 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ David J. Wilson
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
David J. Wilson filed Form 4 for Microbot Medical Inc. (MBOT) on 03 Apr 2026.
Change
- Previous filing in this sequence was filed on 30 Jan 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002052349
Primary reporting owner
Wilson David James
- Relationship
- Director
- Address
- C/O MICROBOT MEDICAL INC., 175 DERBY ST., BLD. 27, HINGHAM
- Signature
- /s/ David J. Wilson
- Signature date
- 02 Apr 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MBOT
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- Shares
- +10,000
- Change %
- Price
- $0.000000*
- Shares after
- 10,000
- Date
- 01 Apr 2026
- Ownership
- Direct
- Underlying class
- Common Stock, par value $0.01 per share
- Underlying amount
- 10,000
- Exercise price
- $2.37
* marks a reported price that did not pass the local price check.